Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018


Regulatory News


Director/PDMR Shareholding

Fri, 10th Nov 2017 16:04


RNS Number : 2255W
N4 Pharma PLC
10 November 2017

10th November 2017

N4 Pharma plc (the "Company")

Notification of Transaction by Directors/PDMRs

The Company was notified on 10th November 2017 that a Person Discharging Management Responsibilities ("PDMR"), had purchased shares in the Company as set out below. Following this purchase, Nigel Theobald now has a total beneficial interest in 12,255,233 Ordinary Shares, representing 16.4% of the issued share capital of the Company.

The Company's share capital consists of 74,714,285 Ordinary Shares with voting rights.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nigel Theobald

2

Reason for the notification

a)

Position/status

CEO and Director

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

N4 Pharma Plc

b)

LEI

213800I841D2RKMFK955

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Oridinary shares BGP 0.0004

ISIN code GB00BYW8QM32

b)

Nature of the transaction

Direct purchase of shares

c)

Price(s) and volume(s)

Price

volume

0.07925

56,656

d)

Aggregated information

- Aggregated price

- Aggregated volume

- Aggregated total

n/a

e)

Date of the transaction

10th November 2017

f)

Place of the transaction

London Stock Exchange, AIM

g)

Additional Information


This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAKFEFEDXFFF


Related Shares:
N4 Pharma (N4P)



Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.